Clinical Trial Update: Pharmacogenomics of Drug Safety in Multiple Sclerosis

View source ↗

Summary

A completed clinical trial update examining pharmacogenomics in drug safety for multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: University of British Columbia | Conditions: Multiple Sclerosis | Status: COMPLETED